RxDoctor Payments Data

Alfred Marc Iloreta, MD

Otolaryngology · New York, NYNPI 1184882136

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Stryker at 25.6% of the total. Reporting peaked in 2019 at $4,059 and has fallen 70.0% since, to $1,219 in 2025. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,023in general payments, 2019–2025

Across 165 payments — averaging $84.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Neurent Medical Limited$3K
  • Intersect ENT, Inc.$2K
  • Medtronic$2K
  • Acclarent, Inc$1K
  • Optinose US, Inc.$827
  • plus $2K from 7 others
$328,094in research payments, 2019–2025

Across 18 payments — averaging $18,227 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • NX Development Corp.$162K
  • AstraZeneca$129K
  • Astrazeneca UK Limited$36K

What the payments were for

  • Consulting fees$7505%
  • Travel & lodging$1031%
  • Food & beverage$13,17094%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,023 in reported general payments places this provider in the 90th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$157,524
Medicare patients
146
Services billed
562

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide66$1,675
Budesonide11$1,401
Mupirocin70$1,004
Azelastine Hcl42$714
Levocetirizine Dihydrochloride45$325
Fluticasone Propionate24$192

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →